Dysfunctional Breathing: Characterisation and Assessment

NCT ID: NCT03043469

Last Updated: 2020-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

141 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-08

Study Completion Date

2021-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dysfunctional breathing (DB) is a respiratory condition characterised by an abnormal breathing pattern, among other complaints, that can occur either in the absence of other pathophysiology (primary DB), e.g. anxiety-related factors, or secondary to cardiopulmonary disease (secondary DB), e.g. asthma. As a consequence, patients may experience breathlessness and present with periods of increased ventilation or erratic breathing, interspersed with episodes of breath holding or deep sighs. In addition to respiratory symptoms, DB also generates non- respiratory symptoms (e.g. dizziness and increased heart rate). It is estimated 1 in 10 people in the United Kingdom (UK) have DB. However, DB remains poorly understood, with no standardised approach to diagnosis and assessment.

The purposes of this study are:

Study 1) To identify physiological, functional and psychological characteristics of participants with DB compared to healthy participants.

Firstly, symptoms, lung function, respiratory gas analysis, exercise capacity, respiratory muscle function, respiratory motion, level of physical activity, quality of life and anxiety \& depression scores will be assessed in 20 participants with primary DB, 20 with secondary DB and compared to 20 healthy participants.

Study 2) To develop an assessment tool based on physiological, functional or psychological variables found to be different between any of the 3 groups in Study 1.

In order to do that, 54 people with DB (between primary and secondary) and 27 people presenting with breathlessness secondary to restrictive lung disease will be assessed. Analysis of these data will determine whether these variables can be used as a diagnostic tool capable of distinguishing DB from restrictive lung diseases characterised by breathlessness.

The recruitment period will be 1-2 years, with an individual participation of 9 days; 1-day on site testing, plus 7-day home activity monitoring, and 1 day to return the activity monitor (which will happen whenever the participant needs to return to the site).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this research, the aims are: 1) to characterise and compare participants with primary dysfunctional breathing (DB), secondary DB and healthy participants, 2) to develop an assessment and identification tool for the population with DB, 3) to identify subgroups of people with DB based on their functional, physiological and psychological characteristics.

In order to do that, in Study 1, there will be a comparison of many different aspects (described below) between three groups of 20 participants each: primary DB, secondary DB and healthy participants. With the results of these comparisons, it will be possible to know more about the differences people with DB have in relation to the healthy population, and to describe their main characteristics. Based on that, in Study 2, it will be possible to select the variables that are different between groups and replicate those tests in an extra 54 participants DB (primary and secondary) and 27 with breathlessness secondary to restrictive lung disease (DB excluded). The second stage will suggest tests to be used when identifying and evaluating this population, and statistically identify subgroups of people with DB based on their characteristics.

It is important to note why the inclusion of healthy participants and participants with breathlessness secondary to restrictive lung disease is important in this research programme. Firstly, it is essential to know the main characteristics of DB in relation to the healthy population. Secondly, the assessment tool has to be able to suggest probability of negative diagnosis of DB for people who do not have DB, and not only positive diagnosis for those who have.

There are no standardised criteria available to diagnose DB. However, experienced chest physicians at Guy's and St Thomas' Foundation Trust (GSTFT) identify probable DB, and provide a clinical diagnosis (CD) according to the following criteria: patients presenting with symptoms that are not concordant with the severity of the underlying health condition (in case of secondary DB), patients presenting with symptoms that persist despite optimal disease management and/or no objective markers of deterioration/exacerbation (in case of secondary DB), patients presenting with symptoms in the presence of negative tests for organic cause/medically unexplained (in case of primary DB), patients presenting with symptoms that are considered functional (in case of primary DB).

Ability to comprehend and/or perform the procedures of this research, as well as the presence of major orthopaedic, neurological or cardiac conditions will be checked by Leyla Osman and the Chest physicians via medical records and when the possible participant is approached to receive information about the study. For example: health conditions in which patients present with an impairment of mental faculties and/or motor function (inability to cycle with no discomfort).

Healthy participants will be contacted via email list at Brunel University London, and via flyers placed on the University's and Hospital's website and murals (attached). Participants with restrictive lung disease will be reached in person or via telephone call when they are referred to respiratory physiotherapy, or via flyers placed on the Hospital's murals. Because there are not plenty of patients with DB, those who are already registered on the Hospital's system as presenting with DB (assessed by a chest physician) will be called. New patients with DB will be contacted in person or via telephone call by the respiratory physiotherapist of the clinical team (Leyla Osman).

If those contacted about this research are interested in taking part in this study, they will be provided with the participant information sheet, have the opportunity to ask any questions they may have and it will be checked if they meet the inclusion criteria. Before starting the assessments, they will be asked to sign the informed consent.

When signing the informed consent, participants will be asked a few questions:

Please, tick this box if you authorise the researchers of this study to have access to your medical records Please, tick this box if you are aware that your General practitioner will be informed about your participation in this research Please, tick this box if you would like to receive a report with your results of the tests performed in this study (within 30 days from the end of your assessments) Please, tick this box if you would like us to contact you in the future to inform you about the final results of this study Please, tick this box if you are participating in other study/ies at this moment. If yes, please mention below what this/these study/ies is/are about and the contact of the person responsible for it The assessments will be performed by Lais Silva Vidotto (respiratory physiotherapist and researcher) at the Hospital/University over a period of approximately 3 hours. Many of these assessments form part of routine hospital investigations for patients with DB. Duration may vary depending on individual needs and limitations, such as time given to recover from any physical or mental effort. Secondly, a physical activity monitor will be given to all participants, which will be returned to the researchers on the next medical appointment at the Hospital/classes at the University (classes at the University in case of healthy participants). During the 3-hour assessment they will have the opportunity to rest whenever is necessary and snacks and refreshments will be provided in the intervals (caffeine-free ingredients).

Assessments and their approximate duration are as follows: demographic information (10 minutes), health-related quality of life questionnaire (SF-36) (5 minutes), Hospital anxiety and depression scale (HADS) (5 minutes), Nijmegen questionnaire (NQ) (5 minutes), Self-evaluation of breathing questionnaire (SEBQ) (5 minutes), Asthma Questionnaire (only for asthmatics) (5 minutes), lung function test (30 minutes), respiratory muscle function (30 minutes, assessment of the respiratory movements (MARM) (10 minutes), breath-hold test (BHT) (20 minutes), slow-breathing task (15 minutes) and the sub-maximal exercise test (10 minutes) (during the two last tests participants will be wearing small and light-weight devices that monitor heart activity, breathing function and blood pressure and take 15 minutes to be placed all together).

Day 1: Hospital assessments (\~3 hours) The tests will be performed in a private room at St Thomas' Hospital or Brunel University London. Participants will be advised to stay 48 hours without practicing exercise. Also, they will be instructed to take all the medicines they normally use and to report their names and doses to the examiner.

1. Patients will be asked about their medical history, date of birth and symptoms. Also, participants' weight and height will be measured.
2. Chest movements while breathing:

At this stage, participants are going to stand still while the researcher will place their hands on the back of their chests in order to evaluate its movements while participants are breathing. This is going to take about 10 minutes.
3. Slow-breathing task:

Participants will be instructed on how to breathe slower (6-10 bpm) for a few minutes (5-15 minutes) and will keep wearing the mask, the heart rate monitor and the arterial blood pressure monitor during this task.
4. Exercise test, breathing and cardiovascular function:

Light-weight devices will be attached to participants' chest (cardiac monitor), in order to evaluate heart function, to their faces (mask-gas analyser) to assess respiratory function, and to their non-dominant arm (arm and finger), to assess blood pressure. The device used to assess blood pressure continuously measures the pulse of the finger, calibrated by an arm cuff, with no discomfort to the participant. Those assessments will be performed while participants rest for five minutes, while they cycle on a bicycle with moderate resistance for six minutes, and while they rest for five more minutes. Just before the exercise test, at the third minute, and just after it, participants will be asked about any leg or breathing discomfort and how mindful they are in relation to discomfort related to the task. Approximate time of this task: 16 minutes.
5. Questionnaires:

Participants will be asked to fill in some questionnaires that will ask about their breathing and quality of life and will take about 25 minutes to complete. Participants will be asked to complete these questionnaires after having the opportunity to ask questions about them.
6. Breath hold test:

Participants will be asked to hold their breath for as long as they can for 3 times, resting for 5 minutes after each one of them, and the researcher will use a stopwatch in order to count the time they are able to do it. The whole task will last in approximately 20 minutes.
7. Lung and respiratory muscle function assessments:

Researchers will use three devices to measure the function of participants' lungs and respiratory muscles. They will be asked to breathe in and out in several different ways, wearing a nose clip, so that researchers can record their general breathing function. This is going to take about one hour to finish.

At the end of the assessment session, participants will be instructed on how to use a device that measures the level of physical activity.

Days 2-8: Physical Activity Monitoring Participants will be asked to wear two small activity monitors attached to their hip for 7 consecutive days, keeping their routine as normal as possible. Participants will have to use the equipment for at least 8 hours/day while they are awake, excluding water activities (e.g. shower) and sleeping, writing down the exact time they put it on and the time they took this off.

Day 9: Return of the activity monitors Participants recruited from Brunel University London will return their physical activity monitors to the researchers on their next visit to the University (for classes, meetings etc.); those recruited from GSTFT will return it on their next hospital appointment.

Although this study requires a cross-sectional design, it may take a long period to be completed, since patients with DB are not easily identified and referred to other health professionals to receive specific diagnosis or treatment. Considering this difficulty in finding participants with DB, justified by the fact that there is no established way of identifying these patients, this research may take 1-2 years to be completed. However, It will enable the researchers to look at every single result and be rigorous with the quality of the data collected. In order to do that, the researchers will not wait for all assessments to be finished to process and plot the data. Every time a participant is evaluated, their results will be organised and plotted within the next few days. It will also enable the data to be statistically analysed when needed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiration Disorder Hyperventilation Syndrome Breathlessness Breath Shortness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy participants

Day 1: Hospital assessments (\~3 hours): Demographic data, Manual Assessment of Respiratory Motion, Slow-breathing task, Six-minute exercise test, Indirect calorimetry, Oxygen saturation monitoring, heart rate variability analysis, continuous measurement of arterial blood pressure, lung function test, the Nijmegen Questionnaire and the Self-Evaluation of Breathing Questionnaire, the Hospital anxiety and depression scale, and the Short-Form Survey Instrument, Breath-hold test, Lung function test, respiratory muscle function assessment.

Days 2-8: Physical Activity Monitoring

Short-form survey instrument

Intervention Type OTHER

Questionnaire with questions about quality of life. Takes about 5 minutes to be completed.

Demographic data

Intervention Type OTHER

height, weight, age, gender, list of comorbidities, health history, level of physical activity, medicines in use. Takes about 10 minutes to be completed.

Hospital Anxiety and Depression Scale

Intervention Type OTHER

Questionnaire with questions about anxiety and depression. Takes about 5 minutes to be completed.

Nijmegen questionnaire

Intervention Type OTHER

Answering questions about symptoms related to breathing. Takes about 5 minutes to be completed.

The Self-evaluation of breathing questionnaire

Intervention Type OTHER

Answering questions about self-evaluation of breathing. Takes about 5 minutes to be completed

six-minute exercise test

Intervention Type OTHER

Cycling against certain load in a bicycle for 6 minutes. Takes about 16 minutes to be completed together with indirect calorimetry, oxygen saturation monitoring, heart rate variability analysis and continuous monitoring of arterial blood pressure).

Indirect calorimetry

Intervention Type OTHER

Breathing through a mask that measures levels of oxygen, carbon dioxide, breathing frequency and others (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Oxygen saturation monitoring

Intervention Type OTHER

The measurement of the amount of oxygen which is attached to haemoglobin molecules (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Heart rate variability analysis

Intervention Type OTHER

Measurement of the variation in the beat-to-beat interval (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Continuous measurement of arterial blood pressure

Intervention Type OTHER

Measurement of blood pressure based on the peripheral pulse using a finger cuff (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Lung function test

Intervention Type DIAGNOSTIC_TEST

Breathing through a mouth-piece in many different ways in order to measure the function of the lungs (non-invasively).

Respiratory muscle function

Intervention Type OTHER

Breathing through a mouth-piece in many different ways in order to measure the function of the respiratory muscles (non-invasively).

Manual assessment of respiratory motion

Intervention Type OTHER

Measure of the movements of the thorax while the participant is breathing (non-invasively).

Breath-hold test

Intervention Type OTHER

Holding the breath a few times for as long as possible.

Physical Activity monitoring

Intervention Type OTHER

Wearing a light-weight activity monitor to be wore on the hip for 7 consecutive days during, at least, 8 hours per day.

Restrictive lung disease group

Day 1: Hospital assessments (\~3 hours): Demographic data, Manual Assessment of Respiratory Motion, Slow-breathing task, Six-minute exercise test, Indirect calorimetry, Oxygen saturation monitoring, heart rate variability analysis, continuous measurement of arterial blood pressure, lung function test, the Nijmegen Questionnaire and the Self-Evaluation of Breathing Questionnaire, the Hospital anxiety and depression scale, and the Short-Form Survey Instrument, Breath-hold test, Lung function test, respiratory muscle function assessment.

Days 2-8: Physical Activity Monitoring

Short-form survey instrument

Intervention Type OTHER

Questionnaire with questions about quality of life. Takes about 5 minutes to be completed.

Demographic data

Intervention Type OTHER

height, weight, age, gender, list of comorbidities, health history, level of physical activity, medicines in use. Takes about 10 minutes to be completed.

Hospital Anxiety and Depression Scale

Intervention Type OTHER

Questionnaire with questions about anxiety and depression. Takes about 5 minutes to be completed.

Nijmegen questionnaire

Intervention Type OTHER

Answering questions about symptoms related to breathing. Takes about 5 minutes to be completed.

The Self-evaluation of breathing questionnaire

Intervention Type OTHER

Answering questions about self-evaluation of breathing. Takes about 5 minutes to be completed

six-minute exercise test

Intervention Type OTHER

Cycling against certain load in a bicycle for 6 minutes. Takes about 16 minutes to be completed together with indirect calorimetry, oxygen saturation monitoring, heart rate variability analysis and continuous monitoring of arterial blood pressure).

Indirect calorimetry

Intervention Type OTHER

Breathing through a mask that measures levels of oxygen, carbon dioxide, breathing frequency and others (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Oxygen saturation monitoring

Intervention Type OTHER

The measurement of the amount of oxygen which is attached to haemoglobin molecules (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Heart rate variability analysis

Intervention Type OTHER

Measurement of the variation in the beat-to-beat interval (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Continuous measurement of arterial blood pressure

Intervention Type OTHER

Measurement of blood pressure based on the peripheral pulse using a finger cuff (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Lung function test

Intervention Type DIAGNOSTIC_TEST

Breathing through a mouth-piece in many different ways in order to measure the function of the lungs (non-invasively).

Respiratory muscle function

Intervention Type OTHER

Breathing through a mouth-piece in many different ways in order to measure the function of the respiratory muscles (non-invasively).

Manual assessment of respiratory motion

Intervention Type OTHER

Measure of the movements of the thorax while the participant is breathing (non-invasively).

Breath-hold test

Intervention Type OTHER

Holding the breath a few times for as long as possible.

Physical Activity monitoring

Intervention Type OTHER

Wearing a light-weight activity monitor to be wore on the hip for 7 consecutive days during, at least, 8 hours per day.

Primary dysfunctional Breathing group

Day 1: Hospital assessments (\~3 hours): Demographic data, Manual Assessment of Respiratory Motion, Slow-breathing task, Six-minute exercise test, Indirect calorimetry, Oxygen saturation monitoring, heart rate variability analysis, continuous measurement of arterial blood pressure, lung function test, the Nijmegen Questionnaire and the Self-Evaluation of Breathing Questionnaire, the Hospital anxiety and depression scale, and the Short-Form Survey Instrument, Breath-hold test, Lung function test, respiratory muscle function assessment.

Days 2-8: Physical Activity Monitoring

Short-form survey instrument

Intervention Type OTHER

Questionnaire with questions about quality of life. Takes about 5 minutes to be completed.

Demographic data

Intervention Type OTHER

height, weight, age, gender, list of comorbidities, health history, level of physical activity, medicines in use. Takes about 10 minutes to be completed.

Hospital Anxiety and Depression Scale

Intervention Type OTHER

Questionnaire with questions about anxiety and depression. Takes about 5 minutes to be completed.

Nijmegen questionnaire

Intervention Type OTHER

Answering questions about symptoms related to breathing. Takes about 5 minutes to be completed.

The Self-evaluation of breathing questionnaire

Intervention Type OTHER

Answering questions about self-evaluation of breathing. Takes about 5 minutes to be completed

six-minute exercise test

Intervention Type OTHER

Cycling against certain load in a bicycle for 6 minutes. Takes about 16 minutes to be completed together with indirect calorimetry, oxygen saturation monitoring, heart rate variability analysis and continuous monitoring of arterial blood pressure).

Indirect calorimetry

Intervention Type OTHER

Breathing through a mask that measures levels of oxygen, carbon dioxide, breathing frequency and others (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Oxygen saturation monitoring

Intervention Type OTHER

The measurement of the amount of oxygen which is attached to haemoglobin molecules (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Heart rate variability analysis

Intervention Type OTHER

Measurement of the variation in the beat-to-beat interval (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Continuous measurement of arterial blood pressure

Intervention Type OTHER

Measurement of blood pressure based on the peripheral pulse using a finger cuff (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Lung function test

Intervention Type DIAGNOSTIC_TEST

Breathing through a mouth-piece in many different ways in order to measure the function of the lungs (non-invasively).

Respiratory muscle function

Intervention Type OTHER

Breathing through a mouth-piece in many different ways in order to measure the function of the respiratory muscles (non-invasively).

Manual assessment of respiratory motion

Intervention Type OTHER

Measure of the movements of the thorax while the participant is breathing (non-invasively).

Breath-hold test

Intervention Type OTHER

Holding the breath a few times for as long as possible.

Physical Activity monitoring

Intervention Type OTHER

Wearing a light-weight activity monitor to be wore on the hip for 7 consecutive days during, at least, 8 hours per day.

Secondary dysfunctional breathing group

Day 1: Hospital assessments (\~3 hours): Demographic data, Manual Assessment of Respiratory Motion, Slow-breathing task, Six-minute exercise test, Indirect calorimetry, Oxygen saturation monitoring, heart rate variability analysis, continuous measurement of arterial blood pressure, lung function test, the Nijmegen Questionnaire and the Self-Evaluation of Breathing Questionnaire, the Hospital anxiety and depression scale, Asthma Control Questionnaire, and the Short-Form Survey Instrument, Breath-hold test, Lung function test, respiratory muscle function assessment.

Days 2-8: Physical Activity Monitoring

Short-form survey instrument

Intervention Type OTHER

Questionnaire with questions about quality of life. Takes about 5 minutes to be completed.

Demographic data

Intervention Type OTHER

height, weight, age, gender, list of comorbidities, health history, level of physical activity, medicines in use. Takes about 10 minutes to be completed.

Hospital Anxiety and Depression Scale

Intervention Type OTHER

Questionnaire with questions about anxiety and depression. Takes about 5 minutes to be completed.

Nijmegen questionnaire

Intervention Type OTHER

Answering questions about symptoms related to breathing. Takes about 5 minutes to be completed.

The Self-evaluation of breathing questionnaire

Intervention Type OTHER

Answering questions about self-evaluation of breathing. Takes about 5 minutes to be completed

six-minute exercise test

Intervention Type OTHER

Cycling against certain load in a bicycle for 6 minutes. Takes about 16 minutes to be completed together with indirect calorimetry, oxygen saturation monitoring, heart rate variability analysis and continuous monitoring of arterial blood pressure).

Indirect calorimetry

Intervention Type OTHER

Breathing through a mask that measures levels of oxygen, carbon dioxide, breathing frequency and others (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Oxygen saturation monitoring

Intervention Type OTHER

The measurement of the amount of oxygen which is attached to haemoglobin molecules (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Heart rate variability analysis

Intervention Type OTHER

Measurement of the variation in the beat-to-beat interval (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Continuous measurement of arterial blood pressure

Intervention Type OTHER

Measurement of blood pressure based on the peripheral pulse using a finger cuff (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Lung function test

Intervention Type DIAGNOSTIC_TEST

Breathing through a mouth-piece in many different ways in order to measure the function of the lungs (non-invasively).

Respiratory muscle function

Intervention Type OTHER

Breathing through a mouth-piece in many different ways in order to measure the function of the respiratory muscles (non-invasively).

Manual assessment of respiratory motion

Intervention Type OTHER

Measure of the movements of the thorax while the participant is breathing (non-invasively).

Breath-hold test

Intervention Type OTHER

Holding the breath a few times for as long as possible.

Physical Activity monitoring

Intervention Type OTHER

Wearing a light-weight activity monitor to be wore on the hip for 7 consecutive days during, at least, 8 hours per day.

Asthma Control Questionnaire

Intervention Type OTHER

Only for asthmatics: answering questions about the control the participant has over this respiratory condition/symptoms.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Short-form survey instrument

Questionnaire with questions about quality of life. Takes about 5 minutes to be completed.

Intervention Type OTHER

Demographic data

height, weight, age, gender, list of comorbidities, health history, level of physical activity, medicines in use. Takes about 10 minutes to be completed.

Intervention Type OTHER

Hospital Anxiety and Depression Scale

Questionnaire with questions about anxiety and depression. Takes about 5 minutes to be completed.

Intervention Type OTHER

Nijmegen questionnaire

Answering questions about symptoms related to breathing. Takes about 5 minutes to be completed.

Intervention Type OTHER

The Self-evaluation of breathing questionnaire

Answering questions about self-evaluation of breathing. Takes about 5 minutes to be completed

Intervention Type OTHER

six-minute exercise test

Cycling against certain load in a bicycle for 6 minutes. Takes about 16 minutes to be completed together with indirect calorimetry, oxygen saturation monitoring, heart rate variability analysis and continuous monitoring of arterial blood pressure).

Intervention Type OTHER

Indirect calorimetry

Breathing through a mask that measures levels of oxygen, carbon dioxide, breathing frequency and others (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Intervention Type OTHER

Oxygen saturation monitoring

The measurement of the amount of oxygen which is attached to haemoglobin molecules (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Intervention Type OTHER

Heart rate variability analysis

Measurement of the variation in the beat-to-beat interval (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Intervention Type OTHER

Continuous measurement of arterial blood pressure

Measurement of blood pressure based on the peripheral pulse using a finger cuff (non-invasively). Takes about 16 minutes to be completed, together with the 6-minute exercise test.

Intervention Type OTHER

Lung function test

Breathing through a mouth-piece in many different ways in order to measure the function of the lungs (non-invasively).

Intervention Type DIAGNOSTIC_TEST

Respiratory muscle function

Breathing through a mouth-piece in many different ways in order to measure the function of the respiratory muscles (non-invasively).

Intervention Type OTHER

Manual assessment of respiratory motion

Measure of the movements of the thorax while the participant is breathing (non-invasively).

Intervention Type OTHER

Breath-hold test

Holding the breath a few times for as long as possible.

Intervention Type OTHER

Physical Activity monitoring

Wearing a light-weight activity monitor to be wore on the hip for 7 consecutive days during, at least, 8 hours per day.

Intervention Type OTHER

Asthma Control Questionnaire

Only for asthmatics: answering questions about the control the participant has over this respiratory condition/symptoms.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SF-36 height, weight, age, gender anxiety and depression questionnaire gas analysis

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with DB (according to the CD)
* healthy people
* aged 18 or over,
* must be able to comprehend and/or perform the procedures of this research
* must be able to consent to participate
* people with signs of breathlessness secondary to restrictive lung disease (DB excluded)

Exclusion Criteria

* people whose condition is unstable or have experienced an exacerbation of symptoms over the last 4 weeks
* patients who are oxygen-dependant (at rest or during exercise),
* those who are on oral steroids or have completed a course of those medications less than four weeks prior to the assessment day,
* those who have major orthopaedic, neurological or cardiac conditions
* those who received breathing retraining before
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sao Paulo

OTHER

Sponsor Role collaborator

Brunel University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lais Silva Vidotto

Ms Lais Silva Vidotto

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Panagiota Smyrni, Dr

Role: STUDY_CHAIR

Brunel University London

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brunel University London

London, Middlesex, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lais S Vidotto, Ms

Role: CONTACT

4401895278024

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lais S Vidotto, BSc MSc

Role: primary

+44 (0)1895 268985

Panagiota Smyrni, PhD

Role: backup

+44 (0)1895 268771

References

Explore related publications, articles, or registry entries linked to this study.

Barker N, Everard ML. Getting to grips with 'dysfunctional breathing'. Paediatr Respir Rev. 2015 Jan;16(1):53-61. doi: 10.1016/j.prrv.2014.10.001. Epub 2014 Nov 25.

Reference Type BACKGROUND
PMID: 25499573 (View on PubMed)

Barker NJ, Jones M, O'Connell NE, Everard ML. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in children. Cochrane Database Syst Rev. 2013 Dec 18;2013(12):CD010376. doi: 10.1002/14651858.CD010376.pub2.

Reference Type BACKGROUND
PMID: 24347088 (View on PubMed)

Bott J, Blumenthal S, Buxton M, Ellum S, Falconer C, Garrod R, Harvey A, Hughes T, Lincoln M, Mikelsons C, Potter C, Pryor J, Rimington L, Sinfield F, Thompson C, Vaughn P, White J; British Thoracic Society Physiotherapy Guideline Development Group. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax. 2009 May;64 Suppl 1:i1-51. doi: 10.1136/thx.2008.110726. No abstract available.

Reference Type BACKGROUND
PMID: 19406863 (View on PubMed)

Brashear RE. Hyperventilation syndrome. Lung. 1983;161(5):257-73. doi: 10.1007/BF02713872. No abstract available.

Reference Type BACKGROUND
PMID: 6138480 (View on PubMed)

Courtney R, Greenwood KM, Cohen M. Relationships between measures of dysfunctional breathing in a population with concerns about their breathing. J Bodyw Mov Ther. 2011 Jan;15(1):24-34. doi: 10.1016/j.jbmt.2010.06.004. Epub 2010 Jul 16.

Reference Type BACKGROUND
PMID: 21147415 (View on PubMed)

Gridina I, Bidat E, Chevallier B, Stheneur C. [Prevalence of chronic hyperventilation syndrome in children and teenagers]. Arch Pediatr. 2013 Mar;20(3):265-8. doi: 10.1016/j.arcped.2012.12.016. Epub 2013 Feb 1. French.

Reference Type BACKGROUND
PMID: 23375424 (View on PubMed)

de Groot EP, Duiverman EJ, Brand PL. Dysfunctional breathing in children with asthma: a rare but relevant comorbidity. Eur Respir J. 2013 May;41(5):1068-73. doi: 10.1183/09031936.00130212. Epub 2012 Sep 27.

Reference Type BACKGROUND
PMID: 23018913 (View on PubMed)

Hagman C, Janson C, Emtner M. A comparison between patients with dysfunctional breathing and patients with asthma. Clin Respir J. 2008 Apr;2(2):86-91. doi: 10.1111/j.1752-699X.2007.00036.x.

Reference Type BACKGROUND
PMID: 20298312 (View on PubMed)

Hagman C, Janson C, Emtner M. Breathing retraining - a five-year follow-up of patients with dysfunctional breathing. Respir Med. 2011 Aug;105(8):1153-9. doi: 10.1016/j.rmed.2011.03.006. Epub 2011 Mar 31.

Reference Type BACKGROUND
PMID: 21454062 (View on PubMed)

Howell JB. The hyperventilation syndrome: a syndrome under threat? Thorax. 1997 Aug;52 Suppl 3(Suppl 3):S30-4. doi: 10.1136/thx.52.2008.s30. No abstract available.

Reference Type BACKGROUND
PMID: 9381424 (View on PubMed)

Jones M, Harvey A, Marston L, O'Connell NE. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in adults. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD009041. doi: 10.1002/14651858.CD009041.pub2.

Reference Type BACKGROUND
PMID: 23728685 (View on PubMed)

Jones M, Troup F, Nugus J, Roughton M, Hodson M, Rayner C, Bowen F, Pryor J. Does manual therapy provide additional benefit to breathing retraining in the management of dysfunctional breathing? A randomised controlled trial. Disabil Rehabil. 2015;37(9):763-70. doi: 10.3109/09638288.2014.941020. Epub 2014 Jul 15.

Reference Type BACKGROUND
PMID: 25026508 (View on PubMed)

LEWIS BI. Hyperventilation syndrome: a clinical and physiological evaluation. Calif Med. 1959 Sep;91(3):121-6.

Reference Type BACKGROUND
PMID: 14416492 (View on PubMed)

Magarian GJ. Hyperventilation syndromes: infrequently recognized common expressions of anxiety and stress. Medicine (Baltimore). 1982 Jul;61(4):219-36. No abstract available.

Reference Type BACKGROUND
PMID: 7045570 (View on PubMed)

Morgan MD. Dysfunctional breathing in asthma: is it common, identifiable and correctable? Thorax. 2002 Oct;57 Suppl 2(Suppl 2):II31-II35. No abstract available.

Reference Type BACKGROUND
PMID: 12364708 (View on PubMed)

Peroni DG, Piacentini GL, Bodini A, Boner AL. Childhood Asthma Control Test in asthmatic children with dysfunctional breathing. J Allergy Clin Immunol. 2008 Jan;121(1):266-7; author reply 267. doi: 10.1016/j.jaci.2007.06.049. Epub 2007 Oct 17. No abstract available.

Reference Type BACKGROUND
PMID: 17920668 (View on PubMed)

Thomas M, McKinley RK, Freeman E, Foy C. Prevalence of dysfunctional breathing in patients treated for asthma in primary care: cross sectional survey. BMJ. 2001 May 5;322(7294):1098-100. doi: 10.1136/bmj.322.7294.1098.

Reference Type BACKGROUND
PMID: 11337441 (View on PubMed)

Thomas M, McKinley RK, Freeman E, Foy C, Price D. The prevalence of dysfunctional breathing in adults in the community with and without asthma. Prim Care Respir J. 2005 Apr;14(2):78-82. doi: 10.1016/j.pcrj.2004.10.007.

Reference Type BACKGROUND
PMID: 16701702 (View on PubMed)

van Dixhoorn J, Duivenvoorden HJ. Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome. J Psychosom Res. 1985;29(2):199-206. doi: 10.1016/0022-3999(85)90042-x.

Reference Type BACKGROUND
PMID: 4009520 (View on PubMed)

van Dixhoorn J, Folgering H. The Nijmegen Questionnaire and dysfunctional breathing. ERJ Open Res. 2015 May 15;1(1):00001-2015. doi: 10.1183/23120541.00001-2015. eCollection 2015 May.

Reference Type BACKGROUND
PMID: 27730128 (View on PubMed)

Vansteenkiste J, Rochette F, Demedts M. Diagnostic tests of hyperventilation syndrome. Eur Respir J. 1991 Apr;4(4):393-9.

Reference Type BACKGROUND
PMID: 1855568 (View on PubMed)

Aadland E, Ylvisaker E. Reliability of the Actigraph GT3X+ Accelerometer in Adults under Free-Living Conditions. PLoS One. 2015 Aug 14;10(8):e0134606. doi: 10.1371/journal.pone.0134606. eCollection 2015.

Reference Type BACKGROUND
PMID: 26274586 (View on PubMed)

ASTRAND PO, RYHMING I. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during sub-maximal work. J Appl Physiol. 1954 Sep;7(2):218-21. doi: 10.1152/jappl.1954.7.2.218. No abstract available.

Reference Type BACKGROUND
PMID: 13211501 (View on PubMed)

Bernardi L, Porta C, Gabutti A, Spicuzza L, Sleight P. Modulatory effects of respiration. Auton Neurosci. 2001 Jul 20;90(1-2):47-56. doi: 10.1016/S1566-0702(01)00267-3.

Reference Type BACKGROUND
PMID: 11485292 (View on PubMed)

Bernardi L, Wdowczyk-Szulc J, Valenti C, Castoldi S, Passino C, Spadacini G, Sleight P. Effects of controlled breathing, mental activity and mental stress with or without verbalization on heart rate variability. J Am Coll Cardiol. 2000 May;35(6):1462-9. doi: 10.1016/s0735-1097(00)00595-7.

Reference Type BACKGROUND
PMID: 10807448 (View on PubMed)

Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69-77. doi: 10.1016/s0022-3999(01)00296-3.

Reference Type BACKGROUND
PMID: 11832252 (View on PubMed)

Bogert LW, van Lieshout JJ. Non-invasive pulsatile arterial pressure and stroke volume changes from the human finger. Exp Physiol. 2005 Jul;90(4):437-46. doi: 10.1113/expphysiol.2005.030262. Epub 2005 Mar 31.

Reference Type BACKGROUND
PMID: 15802289 (View on PubMed)

Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81.

Reference Type BACKGROUND
PMID: 7154893 (View on PubMed)

Brijker F, van den Elshout FJ, Heijdra YF, Bosch FH, Folgering HT. Effect of acute metabolic acid/base shifts on the human airway calibre. Respir Physiol. 2001 Jan;124(2):151-8. doi: 10.1016/s0034-5687(00)00196-1.

Reference Type BACKGROUND
PMID: 11164206 (View on PubMed)

Combes P, Fauvage B. Combined effects of hypocapnia and nicardipine on airway resistance: a pilot study. Eur J Clin Pharmacol. 1997;51(5):385-8. doi: 10.1007/s002280050218.

Reference Type BACKGROUND
PMID: 9049579 (View on PubMed)

Courtney R, Cohen M. Investigating the claims of Konstantin Buteyko, M.D., Ph.D.: the relationship of breath holding time to end tidal CO2 and other proposed measures of dysfunctional breathing. J Altern Complement Med. 2008 Mar;14(2):115-23. doi: 10.1089/acm.2007.7204.

Reference Type BACKGROUND
PMID: 18315509 (View on PubMed)

Courtney R, van Dixhoorn J, Cohen M. Evaluation of breathing pattern: comparison of a Manual Assessment of Respiratory Motion (MARM) and respiratory induction plethysmography. Appl Psychophysiol Biofeedback. 2008 Jun;33(2):91-100. doi: 10.1007/s10484-008-9052-3. Epub 2008 Mar 5.

Reference Type BACKGROUND
PMID: 18320303 (View on PubMed)

Courtney R, van Dixhoorn J, Greenwood KM, Anthonissen EL. Medically unexplained dyspnea: partly moderated by dysfunctional (thoracic dominant) breathing pattern. J Asthma. 2011 Apr;48(3):259-65. doi: 10.3109/02770903.2011.554942. Epub 2011 Feb 22.

Reference Type BACKGROUND
PMID: 21341969 (View on PubMed)

Guelen I, Westerhof BE, Van Der Sar GL, Van Montfrans GA, Kiemeneij F, Wesseling KH, Bos WJ. Finometer, finger pressure measurements with the possibility to reconstruct brachial pressure. Blood Press Monit. 2003 Feb;8(1):27-30. doi: 10.1097/00126097-200302000-00006.

Reference Type BACKGROUND
PMID: 12604933 (View on PubMed)

Han JN, Stegen K, Simkens K, Cauberghs M, Schepers R, Van den Bergh O, Clement J, Van de Woestijne KP. Unsteadiness of breathing in patients with hyperventilation syndrome and anxiety disorders. Eur Respir J. 1997 Jan;10(1):167-76. doi: 10.1183/09031936.97.10010167.

Reference Type BACKGROUND
PMID: 9032511 (View on PubMed)

Hawkes EZ, Nowicky AV, McConnell AK. Diaphragm and intercostal surface EMG and muscle performance after acute inspiratory muscle loading. Respir Physiol Neurobiol. 2007 Mar 15;155(3):213-9. doi: 10.1016/j.resp.2006.06.002. Epub 2006 Jul 18.

Reference Type BACKGROUND
PMID: 16846758 (View on PubMed)

Healy GN, Clark BK, Winkler EA, Gardiner PA, Brown WJ, Matthews CE. Measurement of adults' sedentary time in population-based studies. Am J Prev Med. 2011 Aug;41(2):216-27. doi: 10.1016/j.amepre.2011.05.005.

Reference Type BACKGROUND
PMID: 21767730 (View on PubMed)

Homma I, Masaoka Y. Breathing rhythms and emotions. Exp Physiol. 2008 Sep;93(9):1011-21. doi: 10.1113/expphysiol.2008.042424. Epub 2008 May 16.

Reference Type BACKGROUND
PMID: 18487316 (View on PubMed)

Imholz BP, Wieling W, van Montfrans GA, Wesseling KH. Fifteen years experience with finger arterial pressure monitoring: assessment of the technology. Cardiovasc Res. 1998 Jun;38(3):605-16. doi: 10.1016/s0008-6363(98)00067-4.

Reference Type BACKGROUND
PMID: 9747429 (View on PubMed)

Jack S, Rossiter HB, Pearson MG, Ward SA, Warburton CJ, Whipp BJ. Ventilatory responses to inhaled carbon dioxide, hypoxia, and exercise in idiopathic hyperventilation. Am J Respir Crit Care Med. 2004 Jul 15;170(2):118-25. doi: 10.1164/rccm.200207-720OC. Epub 2004 Apr 1.

Reference Type BACKGROUND
PMID: 15059786 (View on PubMed)

Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health. 1999 Jan;53(1):46-50. doi: 10.1136/jech.53.1.46.

Reference Type BACKGROUND
PMID: 10326053 (View on PubMed)

Joseph CN, Porta C, Casucci G, Casiraghi N, Maffeis M, Rossi M, Bernardi L. Slow breathing improves arterial baroreflex sensitivity and decreases blood pressure in essential hypertension. Hypertension. 2005 Oct;46(4):714-8. doi: 10.1161/01.HYP.0000179581.68566.7d. Epub 2005 Aug 29.

Reference Type BACKGROUND
PMID: 16129818 (View on PubMed)

Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999 Oct;14(4):902-7. doi: 10.1034/j.1399-3003.1999.14d29.x.

Reference Type BACKGROUND
PMID: 10573240 (View on PubMed)

Kozey-Keadle S, Libertine A, Lyden K, Staudenmayer J, Freedson PS. Validation of wearable monitors for assessing sedentary behavior. Med Sci Sports Exerc. 2011 Aug;43(8):1561-7. doi: 10.1249/MSS.0b013e31820ce174.

Reference Type BACKGROUND
PMID: 21233777 (View on PubMed)

Legge BJ, Banister EW. The Astrand-Ryhming nomogram revisited. J Appl Physiol (1985). 1986 Sep;61(3):1203-9. doi: 10.1152/jappl.1986.61.3.1203.

Reference Type BACKGROUND
PMID: 3759759 (View on PubMed)

Lehrer PM, Vaschillo E, Vaschillo B. Resonant frequency biofeedback training to increase cardiac variability: rationale and manual for training. Appl Psychophysiol Biofeedback. 2000 Sep;25(3):177-91. doi: 10.1023/a:1009554825745.

Reference Type BACKGROUND
PMID: 10999236 (View on PubMed)

Lum LC. Hyperventilation and anxiety state. J R Soc Med. 1981 Jan;74(1):1-4. doi: 10.1177/014107688107400101. No abstract available.

Reference Type BACKGROUND
PMID: 6780688 (View on PubMed)

Lyden K, Kozey Keadle SL, Staudenmayer JW, Freedson PS. Validity of two wearable monitors to estimate breaks from sedentary time. Med Sci Sports Exerc. 2012 Nov;44(11):2243-52. doi: 10.1249/MSS.0b013e318260c477.

Reference Type BACKGROUND
PMID: 22648343 (View on PubMed)

Macsween A. The reliability and validity of the Astrand nomogram and linear extrapolation for deriving VO2max from submaximal exercise data. J Sports Med Phys Fitness. 2001 Sep;41(3):312-7.

Reference Type BACKGROUND
PMID: 11533560 (View on PubMed)

Matthews CE, Chen KY, Freedson PS, Buchowski MS, Beech BM, Pate RR, Troiano RP. Amount of time spent in sedentary behaviors in the United States, 2003-2004. Am J Epidemiol. 2008 Apr 1;167(7):875-81. doi: 10.1093/aje/kwm390. Epub 2008 Feb 25.

Reference Type BACKGROUND
PMID: 18303006 (View on PubMed)

McConnell AK, Copestake AJ. Maximum static respiratory pressures in healthy elderly men and women: issues of reproducibility and interpretation. Respiration. 1999;66(3):251-8. doi: 10.1159/000029386.

Reference Type BACKGROUND
PMID: 10364742 (View on PubMed)

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805. No abstract available.

Reference Type BACKGROUND
PMID: 16055882 (View on PubMed)

Mitchell AJ, Bacon CJ, Moran RW. Reliability and Determinants of Self-Evaluation of Breathing Questionnaire (SEBQ) Score: A Symptoms-Based Measure of Dysfunctional Breathing. Appl Psychophysiol Biofeedback. 2016 Mar;41(1):111-20. doi: 10.1007/s10484-015-9316-7.

Reference Type BACKGROUND
PMID: 26400252 (View on PubMed)

Murias JM, Kowalchuk JM, Paterson DH. Speeding of VO2 kinetics with endurance training in old and young men is associated with improved matching of local O2 delivery to muscle O2 utilization. J Appl Physiol (1985). 2010 Apr;108(4):913-22. doi: 10.1152/japplphysiol.01355.2009. Epub 2010 Feb 11.

Reference Type BACKGROUND
PMID: 20150562 (View on PubMed)

Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993 Mar;16:5-40. No abstract available.

Reference Type BACKGROUND
PMID: 8499054 (View on PubMed)

RAHN H, OTIS AB, et al. The pressure-volume diagram of the thorax and lung. Am J Physiol. 1946;146(2):161-78. doi: 10.1152/ajplegacy.1946.146.2.161. No abstract available.

Reference Type BACKGROUND
PMID: 20982947 (View on PubMed)

Sclauser Pessoa IM, Franco Parreira V, Fregonezi GA, Sheel AW, Chung F, Reid WD. Reference values for maximal inspiratory pressure: a systematic review. Can Respir J. 2014 Jan-Feb;21(1):43-50. doi: 10.1155/2014/982374. Epub 2013 Oct 17.

Reference Type BACKGROUND
PMID: 24137574 (View on PubMed)

Stanojevic S, Wade A, Stocks J. Reference values for lung function: past, present and future. Eur Respir J. 2010 Jul;36(1):12-9. doi: 10.1183/09031936.00143209.

Reference Type BACKGROUND
PMID: 20595163 (View on PubMed)

Volianitis S, McConnell AK, Jones DA. Assessment of maximum inspiratory pressure. Prior submaximal respiratory muscle activity ('warm-up') enhances maximum inspiratory activity and attenuates the learning effect of repeated measurement. Respiration. 2001;68(1):22-7. doi: 10.1159/000050458.

Reference Type BACKGROUND
PMID: 11223726 (View on PubMed)

Warburton CJ, Jack S. Can you diagnose hyperventilation? Chron Respir Dis. 2006;3(3):113-5. doi: 10.1191/1479972306cd116ed. No abstract available.

Reference Type BACKGROUND
PMID: 16916004 (View on PubMed)

Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9. doi: 10.1097/00007632-200012150-00008. No abstract available.

Reference Type BACKGROUND
PMID: 11124729 (View on PubMed)

Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998 Nov;51(11):903-12. doi: 10.1016/s0895-4356(98)00081-x.

Reference Type BACKGROUND
PMID: 9817107 (View on PubMed)

Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.

Reference Type BACKGROUND
PMID: 1593914 (View on PubMed)

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.

Reference Type BACKGROUND
PMID: 6880820 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1468-NHS-Dec/2016- 4775-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.